San Donato Group Issues Privacy Notice for Confirm 2 Heart Scan Study

An Italian heart-imaging center has begun enrolling past patients in a privacy-governed follow-up study, and on Monday a detailed data-privacy notice for the project, called Confirm 2, was made public by San Donato group, the hospital group whose research centers are running it.

The study is observational, meaning no new treatment is given.

The people affected are the clearest part of the notice. Confirm 2 looks back at patients who were symptomatic chest-pain evals with no history of coronary artery disease and who underwent a coronary CT angiography — a CCTA, or contrast-enhanced CT scan of the heart’s arteries — at the research center during 2022 and 2023. Those scans and the data attached to them are being re-examined.

Why this matters to patients: the sponsor, Cleerly Inc. of Denver, Colorado, is a company whose products use AI to read coronary CT angiograms. Observational studies like Confirm 2 are how such tools gather the real-world evidence that regulators and cardiologists weigh before the software reaches clinic wards.

Who sees your scan, and how

The notice, issued under Articles 13 and 14 of the EU’s General Data Protection Regulation and the Italian privacy code (Legislative Decree 196/2003, as amended by 101/2018), splits responsibility in two, according to Grupposandonato. The research center is a data controller, and so is the sponsor Cleerly, whose privacy contact is its data protection officer, reachable at [email protected].

The strongest patient protection is the coding. The doctor treating each participant assigns an identifier such as “ab0001” that cannot be traced back to a name, and only the physician and other specifically authorized personnel can connect that code to the person’s identity — and only when strictly necessary, the document states.

Not everything is coded. The notice ranges over ordinary contact details — mobile phone number, email address and the like — and over “particular data” under GDPR definitions, a category that covers health information. Where genetic data or biological samples are in scope, the document says, that will be specified.

Patients decide on scan findings disclosure

  • Your name never reaches the US sponsor: Cleerly receives the coded data without your identity attached.
  • Coded research data can in some cases be safely de-identified — made anonymous — which removes it from privacy rules once that is done.
  • You decide whether to hear about any unexpected finding in your own scan, and to whom it is disclosed if you do.

The clinical point of looking back

A retrospective observational study reuses care that was already delivered. In cardiology this is standard and serves a purpose: patients who arrived in 2022-2023 with chest symptoms but no known coronary disease had CCTA scans — the reference test for ruling out or mapping plaque in the coronary arteries — and what happened to them afterward is precisely the evidence base needed to test whether an AI analysis of those images predicts outcomes.

The word “observational” is doing real work here. No drug is administered, no imaging is repeated for the study, and nothing in the notice suggests a change to your care; the intervention is the analysis of data that already exist, held under good clinical practice standards as the document puts it.

Transfers of data to the United States rest on the Data Privacy Framework, the adequacy arrangement the European Commission adopted in July 2023 that restores a channel for personal data flowing to certified US companies after the Schrems II ruling of 2020 struck down its predecessor. The notice lists that as one of the safeguards chosen.

Your rights on paper

The legal mechanics matter because they give the patient an advantage. Processing is carried out by people specifically authorized per Article 29 GDPR and the corresponding Italian rule, and security measures are mandated under Articles 25 and 32 GDPR. Where an authority orders access, Article 9(3) governs.

Right in the notice Legal basis What it means in practice
Confirmation and access Arts. 15-22 GDPR You can ask the research center whether your data are being processed and see them
Rectification or restriction Arts. 15-22 GDPR Corrections are annotated without altering original records where that would not affect research results (Art. 110(2) privacy code)
Objection and erasure Arts. 17 and 6(1)(e)(f) GDPR You can object; the controllers may not always be able to refuse
Complaint — To the Italian supervisory authority (Garante Privacy)

Requests and the full list of recipients go through the controllers or their data protection officers. One procedural note: standing up directly to the sponsor involves a further step, so the practical channel for questions is the treating research center.

There is a long-standing legal question the notice does not resolve for the reader: whether a company like Cleerly, whose software relates to a medical device, sits differently in the framework than an ordinary data platform — the notice keeps to its GDPR remit and does not say. On that point, the sources hold no answer either.

Warnings worth keeping

The one item patients most often miss: the right to choose whether to learn of incidental findings. A CCTA done for chest pain can incidentally reveal something outside the coronary arteries — lung nodules are the classic example — and the notice builds that choice into the study design rather than assuming it. Participants should name in advance the people to whom such results may be disclosed.

Any person uncomfortable with the retrospective use of their 2022-2023 scan can exercise the objection and erasure rights at the contacts given by the research center. As the document records, personal data collected will also be handled by national competent authorities where applicable.

Where Confirm 2 sits in the development chain

Retrospective data reuse sits between heavy phases of device-evaluation work — cheaper and faster than prospective registries, drawn from real populations that regulators increasingly ask to see. The date to watch is the next step in the study, which the notice does not name; the material covers only the privacy frame.

Column note for the close: the whole architecture — pseudonymized codes, Data Privacy Framework transfers, annotated corrections — exists so that a Denver company can learn from Italian heart scans without ever learning the names behind them, as the privacy notice filed on Monday sets out.

References

  • Italian Privacy Code, Legislative Decree 196/2003 as amended by Legislative Decree 101/2018, Art. 110
  • Observational privacy notice for the Confirm 2 study, Cleerly Inc. and San Donato research center — grupposandonato.it
  • Data Privacy Framework adequacy decision, European Commission — EU-US data transfers

Medical disclaimer: this article reports on a data-privacy notice and study design, not on treatment outcomes. For questions concerning your own participation as a study subject, contact the treating research center or its data protection officer at the addresses given in the notice.

Photo of author

Health Desk

Health Desk at Archyde.

500 Birds Seized in Indiana to Be Euthanized

Gemini Man Streams Free on Pluto TV, BGR Reports